Calliditas Therapeutics AB (publ) CALT

$ 40.0 -0.1%

Quarterly report 2022-Q2
added 08-19-2022

Calliditas Therapeutics AB (publ) Balance Sheet 2011-2024 | CALT

Annual Balance Sheet Calliditas Therapeutics AB (publ)

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-931 M	-996 M	-747 M	-646 M	-56.9 M	5.76 M	-25.2 M	-	-	-	-
Long Term Debt	24.1 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	3.91 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	316 M	145 M	3.76 M	-	-	-	-	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	250 M	57.1 M	30.2 M	29.1 M	41.5 M	10 M	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.43 B	-925 M	-488 M	-456 M	-320 M	-233 M	-176 M	-	-	-	-
Total Assets	1.46 B	1.51 B	845 M	648 M	62.3 M	27.3 M	28.1 M	-	-	-	-
Cash and Cash Equivalents	956 M	996 M	754 M	646 M	-	-	-	-	-	-	-
Book Value	1.46 B	1.26 B	788 M	618 M	33.2 M	-14.2 M	18.1 M	-	-	-	-
Total Shareholders Equity	1.01 B	1.26 B	788 M	618 M	-	-	-	-	-	-	-

All numbers in SEK currency

Quarterly Balance Sheet Calliditas Therapeutics AB (publ)

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	20.6 M	21.9 M	24.1 M	-	3.48 M	1.32 M	878 K	-	-	-	3.58 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	559 M	306 M	316 M	-	103 M	100 M	102 M	-	2.27 M	-	3.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-1.82 B	-1.66 B	-1.45 B	-	-1.21 B	-1.05 B	-919 M	-	-613 M	-	-488 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	1.46 B	1.34 B	1.46 B	-	1.19 B	1.34 B	1.46 B	-	1.49 B	-	845 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	847 M	825 M	956 M	-	709 M	867 M	996 M	-	1.46 B	729 M	754 M	-	-	-	646 M	-	-	-	57.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	1.46 B	1.34 B	1.46 B	-	1.19 B	1.34 B	1.46 B	-	1.49 B	-	845 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	721 M	871 M	1.01 B	-	963 M	1.13 B	1.26 B	-	1.43 B	-	788 M	-	-	-	618 M	-	-	-	33.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in SEK currency